Clinical Research Directory
Browse clinical research sites, groups, and studies.
Postoperative Hypofractionated Intensity-modulated Radiotherapy Endometrial Cancer
Sponsor: Samsung Medical Center
Summary
To investigate the non-inferiority of disease-free survival in women who received hypofractionated intensity-modulated whole pelvic radiation therapy (2.5 Gy x 16 fractions) after curative surgery for stage III endometrial cancer.
Official title: Postoperative Hypofractionated Intensity-modulated Radiotherapy Endometrial Cancer: A Prospective Phase II Trial (POHIM_EM Trial)
Key Details
Gender
FEMALE
Age Range
20 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
92
Start Date
2022-11-01
Completion Date
2031-12-31
Last Updated
2024-06-12
Healthy Volunteers
No
Conditions
Interventions
POHIM_EM
hypofractionated intensity-modulated radiation therapy (2.5 Gy/fraction, 16 fractions)
Locations (1)
Samsung Medical Center
Seoul, South Korea